Skip to main content

Thompson Elizabeth H.Z.

In the past year, 2 open-market sale filings worth $506.4K and no purchases.

Current role at each company

Open-market trades in the past year

Open-market purchases (P) and sales (S) filed in the last 365 days, not counting derivative securities or duplicate filings. Values leave out price outliers.

Bought
–
0 filings
Sold
$506.4K
2 filings
Net
−$506.4K
Bought minus sold
Companies
1
With open-market trades

Trades

Every Form 4 that lists Thompson Elizabeth H.Z. as a reporting owner, including filings made jointly with others, grouped by company. Each row adds up one type of transaction in one filing. Only open-market purchases (P) and sales (S) are shown by default.

ACAD Acadia Pharmaceuticals Inc

EVP, Head of Research & Dev2 trades

Insider trades
Filed (ET)Trade dateFiling delayInsiderTransactionSharesAvg priceValueHolding changeFlags
Jul 31, 2026 (view filing)6:00 PM ETJul 301 dayThompson Elizabeth H.Z.EVP, Head of Research & DevSSale−16.6K$26.13−$432.7K−46.6%19.0K after2 lots
Mar 26, 2026 (view filing)Mar 251 dayThompson Elizabeth H.Z.EVP, Head of Research & DevSSale−3.44K$21.47−$73.7K−51.2%3.28K after

HZNP Horizon Therapeutics Public Ltd Co

EVP, Research & Development4 trades

Insider trades
Filed (ET)Trade dateFiling delayInsiderTransactionSharesAvg priceValueHolding changeFlags
Jul 20, 2022 (view filing)Jul 19-201 dayThompson Elizabeth H.Z.EVP, Research & DevelopmentSSale−6.01K$85.00−$510.6K−46.3%6.97K after3 lots
Jul 11, 2022 (view filing)Jul 74 daysThompson Elizabeth H.Z.EVP, Research & DevelopmentSSale−82$85.01−$6.97K−0.6%13.0K after
Apr 20, 2022 (view filing)Apr 182 daysThompson Elizabeth H.Z.EVP, Research & DevelopmentSSale−8.10K$115.64−$936.5K−38.3%13.1K after
Aug 6, 2021 (view filing)Aug 51 dayThompson Elizabeth H.Z.EVP, Research & DevelopmentSSale−7.54K$106.34−$802.0K−34.7%14.2K after